BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/58/0.1/20.09.24

BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/58/0.1/20.09.24 Share Price

DE000VM7NZ52

Market Closed - Deutsche Boerse AG 11:12:13 28/06/2024 pm IST
0.004 ^EUR	0.00%

Current month	-33.33%
1 month	-20.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart BANK VONTOBEL/CALL/BRISTOL-MYERS SQUIBB/58/0.1/20.09.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	27/06	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	27/06	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	26/06	MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees	26/06	MT

More news

Quotes 5-day view

Date	Price	Change
28/24/28	0.004	0.00%
27/24/27	0.004	-20.00%
26/24/26	0.005	+25.00%
25/24/25	0.004	0.00%
24/24/24	0.004	-50.00%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:12 pm IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Vontobel
WKN	VM7NZ5
ISIN	DE000VM7NZ52
Date issued	29/12/2023
Strike	58 $
Maturity	20/09/2024 (82 Days)
Parity	10 : 1
Emission price	0.17 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.26 €
Lowest since issue	0.003 €
Delta	0.04x
Omega	13.83
Premium	39.98x
Gearing	310.21x
Moneyness	0.7160
Difference Strike	16.47 $
Difference Strike %	+28.40%
Spread	0.015 €
Spread %	75.00%
Intrinsic value	0.000000

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.53 USD

Average target price

53.19 USD

Spread / Average Target

+28.09%

Consensus